B. Demirkan Et Al. , "Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer," Turkish Journal of Cancer , vol.36, no.3, pp.116-125, 2006
Demirkan, B. Et Al. 2006. Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer. Turkish Journal of Cancer , vol.36, no.3 , 116-125.
Demirkan, B., YAVUZŞEN, T., & Alakavuklar, M., (2006). Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer. Turkish Journal of Cancer , vol.36, no.3, 116-125.
Demirkan, Binnaz, TUĞBA YAVUZŞEN, And Mehmet Alakavuklar. "Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer," Turkish Journal of Cancer , vol.36, no.3, 116-125, 2006
Demirkan, Binnaz Et Al. "Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer." Turkish Journal of Cancer , vol.36, no.3, pp.116-125, 2006
Demirkan, B. YAVUZŞEN, T. And Alakavuklar, M. (2006) . "Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer." Turkish Journal of Cancer , vol.36, no.3, pp.116-125.
@article{article, author={Binnaz Demirkan Et Al. }, title={Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer}, journal={Turkish Journal of Cancer}, year=2006, pages={116-125} }